Investor Relations

Latest News

Dec 31, 2020

MPX International Announces Closing of Additional Tranches of Non-Brokered Private Placement Offering

View Press Release

Dec 9, 2020

MPX International Provides Year-End Investor Update

Dec 1, 2020

MPX International's Wholly-Owned Subsidary, Canveda Inc., Receives Licence Amendment From Health Canada Authorizing Production and Sales of Cannabis 2.0 Products

View All News

Investor Presentation

View Presentation

Fourth Quarter 2019 Earnings Conference Call

Jan 29, 2020 • 8:30 am EST

View Event View All

Company Overview

MPX International Corporation is focused on developing and operating assets across the global cannabis industry with an emphasis on cultivating, manufacturing and marketing products which include cannabinoids as their primary active ingredient.

View Management Team View Board of Directors

Investor Contact Information

Company

MPX International Corporation
5255 Yonge Street
Suite 701
Toronto, ON M2N 6P4
Canada
T: 416-840-3725
info@mpxinternationalcorp.com